Ivivigen

Human Centriole and Centrosome Antibody IgG ELISA Kit

MBS039049-10x96StripWells 10x96-Strip-Wells
EUR 6725

Human IgG antibody Laboratories manufactures the ivivigen reagents distributed by Genprice. The Ivivigen reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Ivivigen products are available in stock. Specificity: Ivivigen Category:

Human True insulin ELISA kit

1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit

96T
EUR 700
Description: ELISA

Human True Insulin ELISA Kit

10x96-Strip-Wells
EUR 6725

Human True Insulin ELISA Kit

48-Strip-Wells
EUR 550

Human True Insulin ELISA Kit

5x96-Strip-Wells
EUR 3420

Human True Insulin ELISA Kit

96-Strip-Wells
EUR 765

Human True Insulin GENLISA ELISA

1 x 96 wells
EUR 286

Chemicals information

IV-255

HY-155888 10 mg
EUR 779.23
Description: IV-255 is a selective small molecule inhibitor of the BRG1 bromodomain. IV-255 increases the extent of DNA damage induced by Temozolomide (HY-17364) and Bleomycin (HY-108345). IV-255 inhibits the invasiveness of GBM cells. IV-255 enhances Temozolomide-induced cell death and the apoptosis-inducing activity of Temozolomide[1].

IV-275

HY-155889 Get quote Ask for price
Description: IV-275 is an inhibitor of both BRG1 and BRM bromodomains. IV-275 increases the extent of DNA damage induced by Temozolomide (HY-17364) and Bleomycin (HY-108345). IV-275 inhibits the invasiveness of GBM cells. IV-275 enhances Temozolomide-induced cell death and the apoptosis-inducing activity of Temozolomide[1].

IV-361

HY-139011 10 mg
EUR 5736.02
Description: IV-361 is an orally active and selective CDK7 inhibitor (Ki≤50 nM). IV-361 has anti-cancer activity (US20190256531A1)[1].

InVivoMAb Anti-Human IL2 (Iv0020)

MBS1570045-01mg 0.1mg
EUR 405

InVivoMAb Anti-Human IL2 (Iv0020)

MBS1570045-5x01mg 5x0.1mg
EUR 1520

InVivoMAb Anti-Human IL5 (Iv0021)

MBS1570046-01mg 0.1mg
EUR 405

InVivoMAb Anti-Human IL5 (Iv0021)

MBS1570046-5x01mg 5x0.1mg
EUR 1520

InVivoMAb Anti-Human IL6 (Iv0022)

MBS1570047-01mg 0.1mg
EUR 405

InVivoMAb Anti-Human IL6 (Iv0022)

MBS1570047-5x01mg 5x0.1mg
EUR 1520

InVivoMAb Anti-Human IL9 (Iv0024)

MBS1570049-01mg 0.1mg
EUR 405

InVivoMAb Anti-Human IL9 (Iv0024)

MBS1570049-5x01mg 5x0.1mg
EUR 1520

InVivoMAb Anti-Human EPO (Iv0055)

MBS1570085-01mg 0.1mg
EUR 405

InVivoMAb Anti-Human EPO (Iv0055)

MBS1570085-5x01mg 5x0.1mg
EUR 1520

InVivoMAb Anti-Human HGF (Iv0065)

MBS1570095-01mg 0.1mg
EUR 405

InVivoMAb Anti-Human HGF (Iv0065)

MBS1570095-5x01mg 5x0.1mg
EUR 1520

InVivoMAb Anti-Human FAP (Iv0096)

MBS1570126-01mg 0.1mg
EUR 405

InVivoMAb Anti-Human FAP (Iv0096)

MBS1570126-5x01mg 5x0.1mg
EUR 1520